Citius Pharma's LYMPHIR gains permanent J-code for billing
Inc. and its subsidiary Citius Oncology, Inc. have announced the assignment of a permanent Healthcare Common Procedure Coding System (HCPCS) J-code for their drug LYMPHIR by the Centers for Medicare & ...
Le Lézard14h
Amerisure Modernizes Policy Administration, Underwriting, and Billing Management Capabilities with Guidewire to Increase Business Agility
Amerisure Insurance (Amerisure), a leading provider of commercial property and casualty insurance solutions for U.S.-based construction, manufacturing and healthcare businesses, and Guidewire ...
Citius Pharmaceuticals and Citius Oncology announce J-Code issued for Lymphir
Citius Pharmaceuticals (CTXR) and its oncology-focused subsidiary, Citius Oncology (CTOR) announced that Lymphir has been assigned a unique, ...
Le Lézard14h
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Lucid Diagnostics Inc.  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. , today announced its participation in the 12th ...
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...